MARATTO

article · Gastroenterology Review

Evaluation of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in drug-induced liver injury

20242 citationsOpen accessMenoufia University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

GLDH is a highly specific, simple, real-time, and inexpensive diagnostic and prognostic marker of DILI and shows potential to address this unmet need.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Epilepsy research and treatment
  • Neuroscience and Neuropharmacology Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5114/pg.2024.143153

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.